Assignee
AVM BIOTECHNOLOGY LLC
US·5 granted patents·6 pending applications·8 citations·filing 2016–2022
Top patents by PatentIndex Score
11 records- 0191US10426740B1Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissuesAVM BIOTECHNOLOGY LLC·Filed 2018·Granted Oct 1, 2019·5 cites·13 claims
- 0283US12048705B2Immunoablative therapiesAVM BIOTECHNOLOGY LLC·Filed 2019·Granted Jul 30, 2024·1 cites·21 claims
- 0381US11219628B2Replacement of cytotoxic preconditioning before cellular immunotherapyAVM BIOTECHNOLOGY LLC·Filed 2018·Granted Jan 11, 2022·1 cites·19 claims
- 0475US11446314B2Immunoablative therapiesAVM BIOTECHNOLOGY LLC·Filed 2018·Granted Sep 20, 2022·1 cites·14 claims
- 0566US2022160729A1Replacement of Cytotoxic Preconditioning Before Cellular ImmunotherapyAVM BIOTECHNOLOGY LLC·Filed 2021·Application pending·0 cites
- 0662US2024358829A1Lymphocyte Population and Methods for Producing SameAVM BIOTECHNOLOGY LLC·Filed 2022·Application pending·0 cites
- 0761US10030230B2Personalized production of biologics and method for reprogramming somatic cellsAVM BIOTECHNOLOGY LLC·Filed 2016·Granted Jul 24, 2018·0 cites·6 claims
- 0856US2023210868A1Methods of Treatment Using ICAM-Modulating AgentsAVM BIOTECHNOLOGY LLC·Filed 2021·Application pending·0 cites
- 0955US2023096897A1Lymphocyte Population and Methods for Producing SameAVM BIOTECHNOLOGY LLC·Filed 2021·Application pending·0 cites
- 1054US2023172950A1Glucocorticoid Receptor (GR) Modulators for Treating a SARS-COV-2 VirusAVM BIOTECHNOLOGY LLC·Filed 2021·Application pending·0 cites
- 1148US2020289650A1Stable Glucocorticoid FormulationAVM BIOTECHNOLOGY LLC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AVM BIOTECHNOLOGY LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →